Bright Minds Biosciences (DRUG) EBITDA (2023 - 2026)
Bright Minds Biosciences' (DRUG) quarterly EBITDA came in at $32422.2 in Q4 2024, up 102.62% YoY from $16001.4 in Q1 2024, and down 79.37% on a QoQ basis from $157133.8 in Q2 2024.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) EBITDA (2023 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 2 years of EBITDA data on file, last reported at $32422.2 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -815.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -505.13 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 325.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Bright Minds Biosciences | 456.98 Mn | 234.44 Mn | - | -3.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.75 Mn |
| Mar 31, 2026 | -9.59 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Sep 30, 2025 | -9.99 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 32,422.24 |
| Sep 30, 2024 | -2.08 Mn |
| Jun 30, 2024 | 157,133.80 |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | -1.24 Mn |
| Sep 30, 2023 | -5.50 Mn |
| Jun 30, 2023 | -1.09 Mn |